The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Extracorporeal Membrane Oxygenation (ECMO) Market Research Report 2025
Synopsis
The global Extracorporeal Membrane Oxygenation (ECMO) market was valued at US$ 287.2 million in 2023 and is anticipated to reach US$ 360 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
North American market for Extracorporeal Membrane Oxygenation (ECMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Extracorporeal Membrane Oxygenation (ECMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Extracorporeal Membrane Oxygenation (ECMO) in Respiratory is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Extracorporeal Membrane Oxygenation (ECMO) include MAQUET, Microport, XENIOS, LivaNova, Medtronic, Terumo Cardiovascular and Nipro, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Extracorporeal Membrane Oxygenation (ECMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracorporeal Membrane Oxygenation (ECMO).
Report Scope
The Extracorporeal Membrane Oxygenation (ECMO) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Extracorporeal Membrane Oxygenation (ECMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extracorporeal Membrane Oxygenation (ECMO) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MAQUET
Microport
XENIOS
LivaNova
Medtronic
Terumo Cardiovascular
Nipro
Segment by Type
Veno-Arterial
Arterio-Venous
Veno-Venous
Segment by Application
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Extracorporeal Membrane Oxygenation (ECMO) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Extracorporeal Membrane Oxygenation (ECMO) market was valued at US$ 287.2 million in 2023 and is anticipated to reach US$ 360 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
North American market for Extracorporeal Membrane Oxygenation (ECMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Extracorporeal Membrane Oxygenation (ECMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Extracorporeal Membrane Oxygenation (ECMO) in Respiratory is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Extracorporeal Membrane Oxygenation (ECMO) include MAQUET, Microport, XENIOS, LivaNova, Medtronic, Terumo Cardiovascular and Nipro, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Extracorporeal Membrane Oxygenation (ECMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracorporeal Membrane Oxygenation (ECMO).
Report Scope
The Extracorporeal Membrane Oxygenation (ECMO) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Extracorporeal Membrane Oxygenation (ECMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extracorporeal Membrane Oxygenation (ECMO) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MAQUET
Microport
XENIOS
LivaNova
Medtronic
Terumo Cardiovascular
Nipro
Segment by Type
Veno-Arterial
Arterio-Venous
Veno-Venous
Segment by Application
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Extracorporeal Membrane Oxygenation (ECMO) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Veno-Arterial
1.2.3 Arterio-Venous
1.2.4 Veno-Venous
1.3 Market by Application
1.3.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Respiratory
1.3.3 Cardiac
1.3.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Perspective (2019-2030)
2.2 Extracorporeal Membrane Oxygenation (ECMO) Growth Trends by Region
2.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Extracorporeal Membrane Oxygenation (ECMO) Historic Market Size by Region (2019-2024)
2.2.3 Extracorporeal Membrane Oxygenation (ECMO) Forecasted Market Size by Region (2025-2030)
2.3 Extracorporeal Membrane Oxygenation (ECMO) Market Dynamics
2.3.1 Extracorporeal Membrane Oxygenation (ECMO) Industry Trends
2.3.2 Extracorporeal Membrane Oxygenation (ECMO) Market Drivers
2.3.3 Extracorporeal Membrane Oxygenation (ECMO) Market Challenges
2.3.4 Extracorporeal Membrane Oxygenation (ECMO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extracorporeal Membrane Oxygenation (ECMO) Players by Revenue
3.1.1 Global Top Extracorporeal Membrane Oxygenation (ECMO) Players by Revenue (2019-2024)
3.1.2 Global Extracorporeal Membrane Oxygenation (ECMO) Revenue Market Share by Players (2019-2024)
3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Extracorporeal Membrane Oxygenation (ECMO) Revenue
3.4 Global Extracorporeal Membrane Oxygenation (ECMO) Market Concentration Ratio
3.4.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extracorporeal Membrane Oxygenation (ECMO) Revenue in 2023
3.5 Extracorporeal Membrane Oxygenation (ECMO) Key Players Head office and Area Served
3.6 Key Players Extracorporeal Membrane Oxygenation (ECMO) Product Solution and Service
3.7 Date of Enter into Extracorporeal Membrane Oxygenation (ECMO) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Extracorporeal Membrane Oxygenation (ECMO) Breakdown Data by Type
4.1 Global Extracorporeal Membrane Oxygenation (ECMO) Historic Market Size by Type (2019-2024)
4.2 Global Extracorporeal Membrane Oxygenation (ECMO) Forecasted Market Size by Type (2025-2030)
5 Extracorporeal Membrane Oxygenation (ECMO) Breakdown Data by Application
5.1 Global Extracorporeal Membrane Oxygenation (ECMO) Historic Market Size by Application (2019-2024)
5.2 Global Extracorporeal Membrane Oxygenation (ECMO) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size (2019-2030)
6.2 North America Extracorporeal Membrane Oxygenation (ECMO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2019-2024)
6.4 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size (2019-2030)
7.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2019-2024)
7.4 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Market Size (2019-2030)
8.2 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Market Size by Region (2019-2024)
8.4 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size (2019-2030)
9.2 Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2019-2024)
9.4 Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Market Size (2019-2030)
10.2 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2019-2024)
10.4 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MAQUET
11.1.1 MAQUET Company Detail
11.1.2 MAQUET Business Overview
11.1.3 MAQUET Extracorporeal Membrane Oxygenation (ECMO) Introduction
11.1.4 MAQUET Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
11.1.5 MAQUET Recent Development
11.2 Microport
11.2.1 Microport Company Detail
11.2.2 Microport Business Overview
11.2.3 Microport Extracorporeal Membrane Oxygenation (ECMO) Introduction
11.2.4 Microport Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
11.2.5 Microport Recent Development
11.3 XENIOS
11.3.1 XENIOS Company Detail
11.3.2 XENIOS Business Overview
11.3.3 XENIOS Extracorporeal Membrane Oxygenation (ECMO) Introduction
11.3.4 XENIOS Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
11.3.5 XENIOS Recent Development
11.4 LivaNova
11.4.1 LivaNova Company Detail
11.4.2 LivaNova Business Overview
11.4.3 LivaNova Extracorporeal Membrane Oxygenation (ECMO) Introduction
11.4.4 LivaNova Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
11.4.5 LivaNova Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Detail
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Extracorporeal Membrane Oxygenation (ECMO) Introduction
11.5.4 Medtronic Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
11.5.5 Medtronic Recent Development
11.6 Terumo Cardiovascular
11.6.1 Terumo Cardiovascular Company Detail
11.6.2 Terumo Cardiovascular Business Overview
11.6.3 Terumo Cardiovascular Extracorporeal Membrane Oxygenation (ECMO) Introduction
11.6.4 Terumo Cardiovascular Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
11.6.5 Terumo Cardiovascular Recent Development
11.7 Nipro
11.7.1 Nipro Company Detail
11.7.2 Nipro Business Overview
11.7.3 Nipro Extracorporeal Membrane Oxygenation (ECMO) Introduction
11.7.4 Nipro Revenue in Extracorporeal Membrane Oxygenation (ECMO) Business (2019-2024)
11.7.5 Nipro Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
